CLS-Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 Avenue of the Americas Fl 3, New Yor...Phone Number
(646) 617-3088Website
www.clstherapeutics.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About CLS-Therapeutics
CLS Therapeutics is a biopharmaceutical company focused on developing innovative therapeutic approaches for multiple cancers, particularly pancreatic cancer, through the use of cell-free DNA science. Their lead candidate, CLS-014, is a novel gene therapy designed to eliminate harmful circulating extracellular DNA from patients' blood. Founded by experts in oncology and gene therapy, the company aims to transform treatment for patients with unmet medical needs. CLS Therapeutics is committed to advancing cutting-edge research to deliver transformative gene therapies for cancer patients.Explore more
Popular SearchesCLS-Therapeutics IncCLS TherapeuticsCEO CLS TherapeuticsCls Therapeutics IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CLS-Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CLS-Therapeutics has new funding data
Check if CLS-Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if CLS-Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CLS-Therapeutics launches new products
Earning: See what the market has to say on CLS-Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CLS-Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CLS-Therapeutics
Check out if CLS-Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at CLS-Therapeutics
Find 3 more new buyers
Compare Similar Companies to CLS-Therapeutics
Compare insights from companies similar to CLS-Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CLS-Therapeutics
$5.1M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
CLS-Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CLS-Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CLS-Therapeutics.
CLS-Therapeutics Tech Stack
A closer look at the technologies used by CLS-Therapeutics
CLS-Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CLS-Therapeutics
Sign Up For FreeTo access detailed company insights
CLS Therapeutics is a biopharmaceutical company focused on developing innovative therapeutic approaches for multiple cancers, particularly pancreatic cancer, through the use of cell-free DNA science. Their lead candidate, CLS-014, is a novel gene therapy designed to eliminate harmful circulating extracellular DNA from patients' blood. Founded by ex... Read More
